Current and future Products of interest
The current and future production is focussed on parenteral medicinal products and in-vitro-diagnostics. For example injections are manufactured with varying doses of atropine, midazolam anticonvulsant injections or the antibiotic metronidazole. To be able to respond quickly if required active ingredients, excipients and packaging material for the products manufactured are stored at the pharmacy in Ulm. Figure 3: Product Portfolio7.
Figure 4: Production7.
The expectations placed on the pharmacy show the necessity to cooperate with the pharmaceutical industry and our partners. The most important key words in this context are probably "pooling" and "sharing" in accordance with the NATO doctrine. International cooperation is not only a cost saving tool but it also greatly helps accelerate the development of new drugs since, for instance, the data required for their approval and marketing has to be gathered only once. Furthermore, drugs that are available in several countries will enhance interoperability among the medical services of NATO countries, which is vital, given today’s numerous multinational operations. Two product groups are intensely investigated.
administered by non-medical personnel as part of self and buddy aid while still on the scene of the ongoing chemical threat. This can only be ensured through the use of autoinjectors. An autoinjector, however, is a highly complex drug administration system. For the Bundeswehr, providing autoinjectors is and will continue to be of key importance. Currently trouble spots in particular show the need for such highly specific drugs. Their procurement is expensive and has a long lead time. The Bundeswehr must thus focus on self-sufficient provision of these autoinjectors. An in-depth analysis of the possible options for procurement and provision concluded that in-house production at the Ulm Bundeswehr hospital dispensary would be the key to ensuring reliable provision, including in future scenarios, and thus avoiding dependence on market conditions that are liable to change depending on political parameters. Figure 5: Sealing Ampoules7.
Chemical weapons are condemned in general legal opinion and banned under international law, i.e. the Chemical Weapons Convention1. So far, 192 states have ratified this convention. Twenty years after the Convention entered into force, the sobering conclusion is that a number of states still possess chemical weapons or at least the capability to produce and employ them. To make matters worse, where there is a will to purchase and possibly use such weapons, a state can quickly acquire them by modifying dual-use technologies that, as such, are not banned. The Bundeswehr uses autoinjectors to treat both poisoning resulting from exposure to chemical warfare agents as well as severe pain. Chemical antidotes are only used to counteract nerve agents. There are no specific antidote therapies available to counteract blister agents. Time is of the essence when it comes to treating nerve agent poisoning. The initial dose of a chemical antidote is thus usually
International Review of the Armed Forces Medical Services
Revue Internationale des Services de Santé des Forces Armées